测序试剂市场策略、顶级参与者、增长机会、2028 年分析和预测

  • Report Code : TIPRE00006817
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 211
Buy Now

 

2020 年测序试剂市场价值为 55.3032 亿美元,预计到 2028 年将达到 141.956 亿美元;预计2020 年至 2028 年的复合年增长率为 12.5%。

 

测序试剂用于测序过程中。这些试剂的使用高度依赖于所要获得的结果。它们是测序反应的重要组成部分,也可用于各种其他应用。预计在预测期内,全球研发活动的增加将推动市场的增长。  

测序试剂市场根据试剂类型、技术、应用、最终用户和地理位置进行细分。按地理位置,市场分为北美、欧洲、亚太地区、中东和非洲以及南美和中美。该报告提供了对测序试剂市场的见解和深入分析,重点关注市场趋势、技术进步和市场动态等参数,以及对世界领先市场参与者的竞争格局的分析。    

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

测序试剂市场:

Sequencing Reagents Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

 

市场洞察

 

五年前,基因组测序还仅限于研究环境。现在,它越来越多地应用于临床实践,未来五年,预计将有超过 6000 万名患者的基因组数据在医疗保健领域产生。基因组测序正在迅速转变为临床实践,医疗保健系统的实施得到了政府的大量投资支持,至少有 14 个国家的政府投资总额超过 40 亿美元。这些国家基因组医学计划正在推动现实条件下的变革,同时解决实施障碍并收集证据以供更广泛采用,从而推动市场增长。英国宣布了世界上最大的基因组计划,这是慈善机构和制药公司
之间 2 亿公私合作的一部分。英国已经通过 100,000 基因组计划开发了世界上最大的基因组数据库。该项目由英国创新局牵头,是英国研究与创新的一部分,将资助研究人员和行业将英国卫生服务的数据和现实证据结合起来,创造能够更早、更有效地诊断疾病的新产品和服务。2018年11月,Stilla Technologies宣布完成由Illumina Ventures领投的1830万美元(1600万欧元)A轮融资。该公司将利用这笔资金将其Naica数字PCR系统商业化并开发临床应用。

2018 年 8 月,总部位于马萨诸塞州的 Boston 公司宣布获得 430 万美元的种子资金,并将与基因组测序公司Veritas Genetics 合作。这些资金将支持该公司的使命,即通过创建值得信赖、安全且去中心化的基因组数据市场,开创个人基因组测序时代。2020
年 4 月,总部位于班加罗尔的基因诊断、研究和数据公司MedGenome宣布在新一轮融资中筹集了 5500 万美元(约41.9亿印度卢比),由全球影响力投资公司LeapFrog Investments 领投。此外,MedGenome声称已在印度基因诊断和研究伙伴关系中建立了最大的南亚基因变异数据库。迄今为止,它已经完成了超过 200,000 次基因组测试,并从印度各地的 550 多家医院和 6,000 名临床医生那里获取了样本。

因此,由于制造商和政府在基因组学领域的持续投入,预计测序试剂市场将在预测期内实现增长。

 

测序程序成本下降对市场增长贡献巨大

 

基因组测序的成本一直在大幅下降,在过去的六七年里下降了近一百万倍。近年来,下一代测序的价格也大幅下降。例如,2000 年首次全人类基因组测序的成本超过 37 亿美元,耗时十多年才完成。然而,近年来,该成本已降至 1,000 美元,且整个过程所需的时间也更少。2000 年,测序成本为 37 亿美元,2006 年降至 1,000 万美元,2012 年降至 5,000 美元。成本的下降可以从 2008 年左右基因组测序成本的大幅下降中看出,从大约 1,000 万美元下降到目前的近 1,000 美元。
许多检测服务花费数百美元,降低成本和提高速度不仅可以为他们带来更大的利润空间,还可以提高处理速度并可能吸引更多的消费者。Illumina 提供的最新机器是价格较低的设备,有两种型号 - 850,000 美元的 NovaSeq 5000 和 985,000 美元的 NovaSeq 6000。成本
的快速降低现在有助于临床研究,但更快的速度和更低的价格可能会吸引健康初创公司来帮助消费者。2003 年,首次对整个人类基因组进行测序的成本约为 27 亿美元;然而,DNA 测序公司 Illumina 推出了最新的先进全基因组测序机器,价格不到 100 美元。自成立以来,基因组测序的价格一直在持续下降。 2006 年,Illumina 公司用于测序人类基因组的第一台机器售价为 30 万美元。2014 年,该公司透露,相同测序成本已降至 1,000 美元。Illumina 和 Roche 等主要市场参与者推出了突破性技术,降低了测序成本和时间。2003 年
,国际人类基因组测序联盟开始对整个人类基因组进行测序,进行基因组分析。测序成本约为 26 亿美元(23 亿欧元)。到 2008 年,每个基因组的成本降至 140 万美元(100 万欧元)以下。外显子组测序的成本也变得更便宜。测序一个外显子组的成本为 400 至 500 美元,测序一个基因组的成本为 1,000 至 1,200 美元。由于基因组学领域的进步、不同测序方法和策略的发展等因素,测序成本明显下降。

 

技术洞察                     

 

根据技术,全球测序试剂市场细分为下一代测序、桑格测序和第三代测序。2020 年,下一代测序细分市场占据了最大的市场份额。此外,预计到 2028 年,同一细分市场的市场将以最高速度增长。下一代测序是一种基于单分子测序原理或合成测序提供 RNA 或 DNA 片段大规模并行解码的技术。它会产生大量的测序数据,只能使用专用的生物信息学工具进行分析。这一因素可能会在预测期内推动全球对测序试剂的需求

 

 

 

试剂类型洞察

 

根据试剂类型,全球测序试剂市场分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。对照试剂盒部分在 2020 年占据了最大的市场份额,预计到 2028 年将进一步占据市场主导地位。对照试剂盒提供簇生成、测序和比对的质量控制,以及串扰矩阵生成、定相和预定相的校准控制。

 

应用程序洞察

 

根据应用,全球测序试剂市场细分为农业基因组学和法医学、临床研究、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据了最大的市场份额,预计到 2028 年将进一步占据市场主导地位。新一代测序 (NGS) 和生物信息学工具的结合能够改变肿瘤学研究、诊断和治疗。

 

最终用户洞察

 

根据最终用户,全球测序试剂市场细分为医院和诊所、研究机构、制药和生物技术公司等。医院和诊所部门在 2020 年占据了最大的市场份额,预计到 2028 年将进一步占据市场主导地位。医院和诊所是患者进行诊断并选择治疗方案和替代方案的主要接触点。    

产品发布和并购是全球测序试剂市场参与者广泛采用的策略。以下列出了一些近期的关键产品开发:

2021 年 4 月,QIAGEN NV 推出了 QIAseq DIRECT SARS-CoV-2 Kit,这是一种病毒基因组富集和文库制备解决方案,与 ARTIC 项目协议 [基于引物的下一代测序 (NGS) 方法] 相比,可显著减少文库周转时间和塑料使用量。

2018 年 12 月,生命科学试剂和工具的全球创新者 Abcam plc 与凯杰(苏州)转化医学有限公司(凯杰(苏州))签署了一份谅解备忘录(MoU),以共同开发一系列伴随诊断(CDx)和体外诊断试剂和试剂盒,以满足中国市场的特定需求。

COVID-19 疫情对测序试剂市场产生了积极影响。多家制药公司已经研发出 COVID-19 疫苗,大多数国家也已开始接种疫苗。基因组测序日益成为研究疾病爆发的重要工具,预计未来几个月将对市场的其他部分产生积极影响。另一方面,由于全球运营暂停而导致的供应链中断正在阻碍市场增长。 

 

 

测序试剂市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响测序试剂市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的测序试剂市场细分和地理位置。

Sequencing Reagents Market
  • 获取测序试剂市场的区域特定数据

测序试剂市场报告范围

报告属性细节
2020 年市场规模55.3亿美元
2028 年市场规模142亿美元
全球复合年增长率(2020 - 2028)12.5%
史料2018-2019
预测期2021-2028
涵盖的领域按技术分类
  • 下一代测序
  • 桑格测序
  • 第三代测序
按应用
  • 农业基因组学和法医学
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用
按试剂类型
  • 控制套件
  • 文库套件
  • 模板套件
  • 测序试剂盒
  • 其他试剂类型
按最终用户
  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 华大基因集团
  • F.霍夫曼-罗氏有限公司
  • Fluidigm 公司
  • Illumina 公司
  • LGC 生物搜索技术
  • 加利福尼亚太平洋生物科学公司
  • Qigen
  • Takara Bio 株式会社
  • 赛默飞世尔科技公司

市场参与者密度:了解其对商业动态的影响

测序试剂市场正在快速增长,这得益于最终用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在测序试剂市场运营的主要公司有:

  1. 华大基因集团
  2. F.霍夫曼-罗氏有限公司
  3. Fluidigm 公司
  4. Illumina 公司
  5. LGC 生物搜索技术

免责声明上面列出的公司没有按照任何特定顺序排列。


Sequencing Reagents Market

 

  • 获取测序试剂市场顶级关键参与者概述

 

 

测序试剂——市场细分

 

 

按技术分类

 

  • 下一代测序
  • 桑格测序
  • 第三代测序

 


按试剂类型

 

  • 控制套件
  • 文库套件
  • 模板套件
  • 测序试剂盒
  • 其他试剂类型

 


按应用

 

  • 农业基因组学和法医学
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用

 


按最终用户

 

  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户

 


按地理位置

 

  • 北美

    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲

    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)

    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 中东和非洲 (MEA)

    • 沙特阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲(SCAM)

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

 

公司简介

 

  • 华大基因集团
  • F.霍夫曼-罗氏有限公司
  • Fluidigm 公司
  • Illumina 公司
  • LGC 生物搜索技术
  • 加利福尼亚太平洋生物科学公司
  • Qigen
  • Takara Bio 株式会社
  • 赛默飞世尔科技公司
  • Trilink 生物技术公司
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the sequencing reagents market?

The sequencing reagents market majorly consists of the players such BGI Group, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Illumina, Inc., LGC Biosearch Technologies, Pacific Biosciences of California, Inc., Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc., and Trilink Biotechnologies among others.

What are the driving factors for the sequencing reagents market across the globe?

The factors that are driving growth of the market are growing funding for genomics, declining cost of sequencing procedures and increasing prevalence of chronic diseases are anticipated to drive the growth of the global sequencing reagents market during the forecast period. However, dearth of skilled professionals is hindering the market growth.

What are sequencing reagents?

Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. An increase in R&D activities worldwide is expected to drive the growth of the market during the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Sequencing Reagents Market

  1. BGI Group
  2. F. Hoffmann-La Roche Ltd.
  3. Fluidigm Corporation
  4. Illumina, Inc.
  5. LGC Biosearch Technologies
  6. Pacific Biosciences of California, Inc.
  7. Qiagen
  8. Takara Bio, Inc.
  9. Thermo Fisher Scientific, Inc.
  10. Trilink Biotechnologies

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.